← Back to Clinical Trials
Recruiting NCT06511557

NCT06511557 Comparison of Effect of Virtual Reality and Kinetic Chain Exercises in Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06511557
Status Recruiting
Phase
Sponsor Riphah International University
Condition Knee Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2023-11-16
Primary Completion 2024-08-01

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Non immersive virtual reality ( xbox kinetic)Kinetic chain exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2023-11-16 with a primary completion date of 2024-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

It is necessary to explore the novel rehabilitation strategies to treat knee osteoarthritis. Although kinetic chain exercises have shown efficacy but there is growing interest in Virtual Reality training using Xbox Kinect because it has the potential to enhance motivation and patient's adherence to Rehabilitation. The aim of this study is to compare the effectiveness of both interventions and provide a valuable insight to optimize the therapeutic strategies for treating knee osteoarthritis.

Eligibility Criteria

Inclusion Criteria: * Both male \& female * Age 50 or older. * Body mass index (BMI) between 18.9kg/m2 and 29.9 kg/m2. * Diagnosed with Grade II knee OA * Have knee pain \> 4 on NPRS * Ability to engage in moderate physical activity. Exclusion Criteria: * Severe comorbidities limiting physical activity. * History of Hip and Knee arthroplasty. * Cognitive impairments affecting comprehension

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 033324390125

Principal Investigator

syed shakil urrehman, PhD

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06511557 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06511557 currently recruiting?

Yes, NCT06511557 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06511557 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06511557 clinical trial?

NCT06511557 is sponsored by Riphah International University. The principal investigator is syed shakil urrehman, PhD at Riphah International University. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology